WID Researchers Collaborate on UW2020 Projects
Researchers at the Wisconsin Institute for Discovery are co-Principal Investigators and co-Investigators on four UW2020: WARF Discovery Initiative projects.
WID researchers are engaged in cancer research from many different perspectives, including precision medicine, immunotherapy development, epigenic inquiry, and several omics-related angles. With a focus on Healthy People, WID is committed to working with its campus partners to understand and treat cancer more effectively.
Researchers at the Wisconsin Institute for Discovery are co-Principal Investigators and co-Investigators on four UW2020: WARF Discovery Initiative projects.
Investigators from WID are among the recipients of the latest round of UW2020 awards.
One of the UW Carbone Cancer Center members presenting is WID’s Peter Lewis. His work focuses on how genes are turned on and off during embryonic development, and how misregulation in those genes can lead to some childhood cancers.
Mark Klein and Peter Lewis were recognized for their cancer research awards from The Ride, sponsored by the UW Carbone Cancer Center, at a recent Wisconsin Men’s Hockey game.
Kris Saha with colleagues David Beebe and Christian Capitini aim to develop improved methods for making CAR T-Cells with a two-year grant from the NSF.
The Epigenetics theme at WID is putting mass spectrometry to use in new ways with specialized workflows designed to uncover the mysteries of chromatin.
Xuehua Zhong, Assistant Professor in WID’s Epigenetics Theme studies the epigenetic connections mammals share with plants.
Through an Environmental Protection Agency initiative, WID researchers are playing a key role in learning how toxins impact human health and the environment.
Rupa Sridharan, Assistant Professor of Cell and Regenerative Biology at Wisconsin Institute for Discovery explains how she increased reprogramming efficiency to get pluripotent stem cells.